Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Dec 15;49(12):1861-7.
doi: 10.1086/648426.

Dissemination of methicillin-resistant Staphylococcus aureus USA300 sequence type 8 lineage in Latin America

Affiliations

Dissemination of methicillin-resistant Staphylococcus aureus USA300 sequence type 8 lineage in Latin America

Jinnethe Reyes et al. Clin Infect Dis. .

Abstract

Background: Methicillin-resistant Staphylococus aureus (MRSA) is an important nosocomial and community-associated (CA) pathogen. Recently, a variant of the MRSA USA300 clone emerged and disseminated in South America, causing important clinical problems.

Methods: S. aureus isolates were prospectively collected (2006-2008) from 32 tertiary hospitals in Colombia, Ecuador, Peru, and Venezuela. MRSA isolates were subjected to antimicrobial susceptibility testing and pulsed-field gel electrophoresis and were categorized as health care-associated (HA)-like or CA-like clones on the basis of genotypic characteristics and detection of genes encoding Panton-Valentine leukocidin and staphylococcal cassette chromosome (SCC) mec IV. In addition, multilocus sequence typing of representative isolates of each major CA-MRSA pulsotype was performed, and the presence of USA300-associated toxins and the arcA gene was investigated for all isolates categorized as CA-MRSA.

Results: A total of 1570 S. aureus were included; 651 were MRSA (41%)--with the highest rate of MRSA isolation in Peru (62%) and the lowest in Venezuela (26%)--and 71%, 27%, and 2% were classified as HA-like, CA-like, and non-CA/HA-like clones, respectively. Only 9 MRSA isolates were confirmed to have reduced susceptibility to glycopeptides (glycopeptide-intermediate S. aureus phenotype). The most common pulsotype (designated ComA) among the CA-like MRSA strains was found in 96% of isolates, with the majority (81%) having a < or =6-band difference with the USA300-0114 strain. Representative isolates of this clone were sequence type 8; however, unlike the USA300-0114 strain, they harbored a different SCCmec IV subtype and lacked arcA (an indicator of the arginine catabolic mobile element).

Conclusion: A variant CA-MRSA USA300 clone has become established in South America and, in some countries, is endemic in hospital settings.

PubMed Disclaimer

Conflict of interest statement

Potential conflict of interest

Dr. Arias has received lecture fees from Pfizer and Merck and grant support from Pfizer. Dr. Murray has grant support from Johnson & Johnson, Astellas, Palumed and Intercell and has served as consultant for Astellas Pharma US Inc & Theravance Inc., Cubist, Targanta Therapeutics Corporation, Johnson & Johnson, Pfizer, AstraZeneca and Wyeth-Ayerst. Dr. Zurita reports research grants from Pfizer and Wyeth. Dr. Guzman has served as consultant for Pfizer, Merck and Co, Wyeth and Becton and Dickinson. All other authors no conflicts of interest.

Figures

Figure 1
Figure 1
Pulsed field gel electrophoresis (PFGE) of CA-like MRSA isolate representatives of the ComA pulsotype from different countries. Lane 1, S. aureus NCTC 8325; lane 2, Col-177 (Colombia); lane 3, HUV-01 (Colombia); lane 4, CA-12 (Colombia); lane 5, C609 (Colombia), lane 6, V2125 (Venezuela); lane 7, E403 (Ecuador); lane 8, USA300-0114 strain; lane 9, USA300 varrying SCCmec IVb (Nebraska); lane 10, USA400 (N. Dakota); lane 11, S. aureus NCTC 8325.

References

    1. Grundmann H, Aires de Sousa M, Boyce J, Tiemersma E. Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat. Lancet. 2006;68:874–85. - PubMed
    1. Zetola N, Francis JS, Nuermberger EL, Bishai WR. Community-acquired meticillin-resistant Staphylococcus aureus: an emerging threat. Lancet Infect Dis. 2005;5:275–86. - PubMed
    1. Maree CL, Daum RS, Boyle-Vavra S, Matayoshi K, Miller LG. Community-associated meticillin-resistant Staphylococcus aureus isolates causing healthcare-associated infections. Emerg Infect Dis. 2007;13:236–42. - PMC - PubMed
    1. Sieradzki K, Roberts RB, Haber SW, Tomasz A. The Development of Vancomycin Resistance in a Patient with Meticillin-Resistant Staphylococcus aureus Infection. N Engl J Med. 1999;340:517–23. - PubMed
    1. Cui L, Ma XX, Sato K, et al. Cell wall thickening is a common feature of vancomycin resistance in Staphylococcus aureus. J Clin Microbiol. 2003;41:5–14. - PMC - PubMed

Publication types

MeSH terms